Highlights d Two-component protein nanoparticles display multiple copies of the SARS-CoV-2 spike d Spike protein nanoparticles enhance cognate B cell activation in vitro d Vaccination induces potent neutralization in mice, rabbits, and cynomolgus macaques d Vaccination protects macaques against a high-dose SARS-CoV-2 challenge
Highlights d Two-component protein nanoparticles display multiple copies of the SARS-CoV-2 spike d Spike protein nanoparticles enhance cognate B cell activation in vitro d Vaccination induces potent neutralization in mice, rabbits, and cynomolgus macaques d Vaccination protects macaques against a high-dose SARS-CoV-2 challenge
The SARS-CoV-2 pandemic is continuing to disrupt personal lives, global healthcare systems and economies. Hence, there is an urgent need for a vaccine that prevents viral infection, transmission and disease. Here, we present a two-component protein-based nanoparticle vaccine that displays multiple copies of the SARS-CoV-2 spike protein. Immunization studies show that this vaccine induces potent neutralizing antibody responses in mice, rabbits and cynomolgus macaques. The vaccine-induced immunity protected macaques against a high dose challenge, resulting in strongly reduced viral infection and replication in upper and lower airways. These nanoparticles are a promising vaccine candidate to curtail the SARS-CoV-2 pandemic.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.